
Obesity Therapies: What Will the Future Bring? - Medscape
Oct 15, 2024 · Treating the Causes The future of obesity therapy might also be directed at the originating factors that cause it, Blüher suggested, adding that "treating the causes is a dream of mine."
Does Vitamin D Deficiency Cause Obesity or Vice Versa?
Dec 27, 2022 · Vitamin D deficiency has been cited as a possible cause of obesity. Dr Caroline Apovian talks about vitamin D and whether it has a role in obesity development.
Inflammation and Obesity: Which Starts the Cycle? - Medscape
May 2, 2025 · Obesity can lead to a chronic inflammatory state within the body. What drives this inflammation? Does inflammation, in turn, promote obesity? And what are the potential therapeutic …
Tirzepatide Tops TRT for Men With Hypogonadism and Obesity
Jul 23, 2025 · San Francisco — Tirzepatide is a promising treatment for metabolic hypogonadism in men with obesity, new research suggested. In a study of 83 men with obesity, functional hypogonadism, …
Obesity-Related Cancer Deaths More Than Triple - Medscape
Jul 15, 2025 · Rural, older, Black, and female Americans bear the brunt of the surge in obesity-related cancer mortality, new data show.
'Psychological Weight' Crucial in Patients With Obesity - Medscape
Jul 30, 2024 · How do psychological factors affect the treatment of obesity? Psychological factors are important triggers for weight gain. As the degree of obesity increases, so does the predisposition to …
Stop the Patient Blame Game: What Actually Causes Obesity?
Mar 1, 2019 · Is it a lack of willpower? Are people choosing to overeat? Dr Dhurandhar reviews the most common misperceptions about obesity and discusses some of its real causes.
A New Weight Loss Drug With No Side Effects? Yes…So Far
Dec 18, 2024 · Researchers have achieved impressive results in animal studies with a new weight-loss drug that has no GLP-1-style side effects — especially muscle loss.
Obesity in the US Projected to Skyrocket by 2050 - Medscape
Nov 14, 2024 · If current trends continue, more than 250 million Americans will have overweight or obesity in the next quarter-century.
Tirzepatide Reduces Heart Failure Events in HFpEF With Obesity
SUMMT has shown for the first time that a drug can reduce major heart failure clinical outcomes in patients with heart failure and a preserved ejection fraction and obesity.